Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, August 11, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Study Points to New Mechanism for Schizophrenia Drug Candidate Evenamide
Life Sciences Times
-
August 11, 2025
Pharma
KalVista Drug for Hereditary Angioedema Keeps Orphan Status in EU
Life Sciences Times
-
August 11, 2025
Pharma
First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment
Life Sciences Times
-
August 11, 2025
Pharma
Palleon Pharmaceuticals Doses First Patient in Phase 2 Trial of E-602 for Autoimmune Kidney Disease
Life Sciences Times
-
August 7, 2025
Pharma
Astria Therapeutics Strikes $32 Million Licensing Deal with Kaken Pharmaceutical for HAE Drug in Japan
Life Sciences Times
-
August 6, 2025
Pharma
908 Devices Announces Launch of Initial Public Offering
Life Sciences Times
-
December 14, 2020
0
Pharma
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
Life Sciences Times
-
December 12, 2020
0
Pharma
Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for HER2 Positive Metastatic Breast Cancer
Life Sciences Times
-
December 11, 2020
0
Pharma
Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
Life Sciences Times
-
December 10, 2020
0
Medtech
SciNeuro Pharmaceuticals Launches to Bring Innovative Treatments for CNS Diseases
Life Sciences Times
-
December 8, 2020
0
1
...
74
75
76
Page 76 of 76
Most Read
First FDA-Approved Treatment for MacTel Administered Following Commercial Launch
August 11, 2025
Study Points to New Mechanism for Schizophrenia Drug Candidate Evenamide
August 11, 2025
FDA Clears Thermo Fisher Test to Match Lung Cancer Patients With Newly Approved HER2-Targeted Drug
August 11, 2025
SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team
August 11, 2025